CBIO Average Annual Return 10 Years

Growth of $10,000.00
With Dividends Reinvested Into CBIO

Also see:
• CBIO stock yearly return 2016
• CBIO stock yearly return 2017
• CBIO stock yearly return 2018
• CBIO stock yearly return 2019
• CBIO stock yearly return 2020
• CBIO stock yearly return 2021
• CBIO stock yearly return 2022
• CBIO stock yearly return 2023
• CBIO stock yearly return 2024
• CBIO stock yearly return 2025
• CBIO YTD return

Compare CBIO average annual return versus benchmarks:

S&P Average Annual Return
Dow Average Annual Return
Nasdaq 100 Average Annual Return
Russell 2000 Average Annual Return
Gold Average Annual Return
10 Year Treasury Average Annual Return

Start date:	02/18/2016
End date:	02/17/2026
Start price/share:	$8,040.00
End price/share:	$9.33
Starting shares:	1.24
Ending shares:	4.34
Dividends reinvested/share:	$167.00
Total return:	-99.59%
CBIO Average Annual Return:	-42.34%
Starting investment:	$10,000.00
Ending investment:	$40.50

CBIO average annual return is presented with the assumption of reinvestments of any dividends on ex-date.

GlycoMimetics, Inc. is a late clinical-stage biotechnology company discovering and developing glycobiology-based therapies for cancers, including acute myeloid leukemia (AML) and for inflammatory diseases. It is developing a pipeline of glycomimetics, which are small molecules that mimic the structure of carbohydrates involved in biological processes, to inhibit disease-related functions of carbohydrates, such as the roles they play in inflammation, cancer and infection. Its drug candidates include Uproleselan, GMI-1687, Galectin Antagonists and GMI-1359. The CBIO average annual return 10 years is shown above.

The Average Annual Return on the CBIO average annual return 10 years page and across the coverage universe of our site, is a measure of the annualized return over the past ten years (or specified start date) for a given investment (up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window to capture long-term trends.

Thus, researching Average Annual Returns is good practice for investors — whether CBIO average annual return 10 years or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the CBIO average annual return calculation with any dividends reinvested as applicable (on ex-dates).

Quotes delayed 20 minutes

Free CBIO Email Alerts:
Get Dividend Alerts

Get SEC Filing Alerts

10 Most Oversold Stocks in the S&P

10 Most Overbought Stocks in the S&P

10 ETFs With Stocks That Insiders Are Buying

10 ETFs With Most Upside To Analyst Targets

The DividendRank Top 25

Warren Buffett Dividend Stocks

10 Cheap Dividend Stocks Under $10

10 Energy Stocks You Can Buy Cheaper Than Insiders Did

10 Top DividendRank'ed Energy Stocks

The 10 Highest Yielding Preferred Stocks

The 15 Most Active Call & Put Options of the S&P 500 Components

Video: Don't Forget Dividends in Average Annual Return!

If the video does not load after a few moments, Upgrade to the Latest Flash Player.

Crescent Biopharma (CBIO) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:

CBUS Average Annual Return
CCCC Average Annual Return
CCEL Average Annual Return
CCRN Average Annual Return
CCXI Average Annual Return
CDNA Average Annual Return
CDRE Average Annual Return
CELC Average Annual Return
CELU Average Annual Return
CELZ Average Annual Return
More Healthcare companies »

What has the average annual return been for CBIO over the past ten years?

✔️Accepted answer: The ten year CBIO average annual return has been -42.34% with dividends reinvested.

When you say 'with dividends reinvested' what does that mean?

✔️Accepted answer: That means that each time the stock goes ex-dividend, the average annual return calculation then factors in how that dividend amount could have been reinvested into more shares of CBIO at the then-current price — often this is referred to as 'compounding' and is very important when considering average annual return over a long period like a full decade.

What start date was used in your CBIO average annual return calculation?

✔️Accepted answer: The start date was 02/18/2016.

What end date was used in your CBIO average annual return calculation?

✔️Accepted answer: The end date was 02/17/2026.

If I had invested $10,000 into CBIO ten years ago, how much would I have today?

✔️Accepted answer: With dividends reinvested, as of 02/17/2026, you would have $40.50.

What does that work out to on a total return basis?

✔️Accepted answer: The CBIO ten year total return ending 02/17/2026 works out to -99.59%.

CBIO Average Annual Return 10 Years | www.AverageAnnualReturn.com | Copyright © 2021 - 2026, All Rights Reserved